demonstrated that cancer cell-derived IgG could bind to platelet FcγRIIa, initiate FcγRIIa-signaling pathway and mediate platelet activation and that knocking down of IgG significantly reduced CD62P expression, aggregation, and ATP release of platelets (119). This evidence concerns the gene SELP and cancer.